Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01427179 · ClinicalTrials.gov registry record
Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)
A clinical trial, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 2,000
- Enrollment target
NCT01427179: Recruiting study, sponsored by Mayo Clinic.
NCT01427179 is a clinical trial that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 2,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01427179 is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
The purpose of the research is to identify mutations (defects in the genetic blueprint) that cause spontaneous coronary artery dissection (SCAD), in other words, spontaneous tears in blood vessels that supply the heart. Some mutations may be inherited (passed on) from a parent without an apparent blood vessel problem while others may develop for the first time in the affected person.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2011-05 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01427179
The ClinicalTrials.gov registry entry for NCT01427179 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01427179 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01427179 about?
NCT01427179 is a clinical study titled "Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)". The purpose of the research is to identify mutations (defects in the genetic blueprint) that cause spontaneous coronary artery dissection (SCAD), in other words, spontaneous tears in blood vessels that supply the heart. Some mutations may be inherited (passed on) from a parent without an apparent b...
What is the current status of trial NCT01427179?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2011-05. Estimated completion is 2030-12.
Who is sponsoring clinical trial NCT01427179?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.